Neurotherapia Inc.

Neurotherapia Inc. focuses on neurodegenerative disorders, with clinical research centered on mild cognitive impairment and mild to moderate Alzheimer’s disease. The company’s funded studies reflect interest in conditions where cognitive decline and disease progression are key therapeutic concerns.

• Alzheimer’s disease
• mild cognitive impairment
• cognitive decline

Its research activity is directed toward clinical evaluation in patient populations affected by early and established cognitive impairment.